https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-paroxetine-extended-release-tablets-194722026-03-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/shreehas-tambe-appointed-ceo-managing-director-of-biocon-194732026-03-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-acquires-excellergy-to-bolster-allergy-portfolio-194742026-03-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-stakes-claim-to-redefine-skin-disease-treatment-at-global-dermatology-summit-194752026-03-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/eli-lilly-drug-shows-4-year-relief-for-eczema-patients-study-finds-194762026-03-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazenecas-breakthrough-copd-drug-tozorakimab-slashes-flare-ups-in-landmark-phase-iii-trials-194772026-03-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/otsuka-pharma-to-acquire-transcend-therapeutics-in-1225-billion-deal-194782026-03-28T00:00:00+05:30always0.9